Blanchard Cheryl R's Form 4 filing
Anika Therapeutics, Inc. (ANIK) · filed Mar 14, 2022
- Accession no.
- 0001171843-22-001833
- Filed
- Mar 14, 2022
- Trade date
- Mar 11, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $207.1K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blanchard Cheryl RCIK 0001326530 | Director, Officer (President, CEO, Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2022 | Common Stock | PPurchaseAcquired | +4,287 | $25.36 | +$108,718.32 | 56,179 | Direct | |
| Mar 11, 2022 | Common Stock | PPurchaseAcquired | +3,813 | $25.81 | +$98,413.53 | 59,992 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.